Literature DB >> 35122633

MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2.

L Liu1, B Guo1, Y Han1, S Xu1, S Liu2.   

Abstract

PURPOSE: Oral squamous cell carcinoma (OSCC) is the most frequent type of oral cancer and is associated with high mortality. Membrane-associated ring-CH type finger 1 (MARCH1) is an E3 ubiquitin ligase with roles in immune regulation and cancer development. Whether MARCH1 has a specific role in OSCC, and if so through what mechanism, has not been explored.
METHODS: Immunohistochemistry was performed to examine MARCH1 expression in OSCC clinical samples and adjacent paracancerous tissues. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and Western blot were conducted to determine mRNA expression and protein levels, respectively. Knockdown and overexpression experiments were carried out to evaluate the effects of MARCH1 on proliferation and apoptosis. To test protein-protein interaction, co-immunoprecipitation assay was performed. Finally, tumor cell grafting was utilized to test the function of MARCH in vivo.
RESULTS: High MARCH1 expression in OSCC clinical samples correlated with poor patient prognosis. Functionally, MARCH1 knockdown in OSCC cells suppressed proliferation and promoted apoptosis, while MARCH1 overexpression displayed the opposite effects. We identified PH Domain And Leucine Rich Repeat Protein Phosphatase (PHLPP) 2 as an important target of MARCH1. Mechanistically, MARCH1 interacted with PHLPP2 and promoted PHLPP2 ubiquitination. Lastly, MARCH1 knockdown suppressed OSCC tumorigenicity in vivo and increased PHLPP2 protein level.
CONCLUSION: Our study uncovered a function of MARCH1 in OSCC and identified PHLPP2 as an important target of MARCH1 to modulate OSCC cell proliferation and apoptosis.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  AKT; Apoptosis; MARCH1; Oral squamous cell carcinoma (OSCC); PHLPP2; Proliferation

Mesh:

Substances:

Year:  2022        PMID: 35122633     DOI: 10.1007/s12094-021-02769-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  3 in total

Review 1.  Metastasis from oral cancer: an overview.

Authors:  Juliana Noguti; Carolina Foot Gomes De Moura; Gustavo Protasio Pacheco De Jesus; Victor Hugo Pereira Da Silva; Thais Ayako Hossaka; Celina Tijuko Fujiyama Oshima; Daniel Araki Ribeiro
Journal:  Cancer Genomics Proteomics       Date:  2012 Sep-Oct       Impact factor: 4.069

2.  Alcohol-dehydrogenase (ADH1B) Arg48His polymorphism in Basque Country patients with oral and laryngeal cancer: preliminary study.

Authors:  Xabier Marichalar-Mendia; Amelia Acha-Sagredo; Maria Jose Rodriguez-Tojo; Natalia Rey-Barja; Miriam Hernando-Rodriguez; Jose Ignacio Aguirregaviria; Jose Manuel Aguirre-Urizar
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

Review 3.  The Akt pathway in oncology therapy and beyond (Review).

Authors:  George Mihai Nitulescu; Maryna Van De Venter; Georgiana Nitulescu; Anca Ungurianu; Petras Juzenas; Qian Peng; Octavian Tudorel Olaru; Daniela Grădinaru; Aristides Tsatsakis; Dimitris Tsoukalas; Demetrios A Spandidos; Denisa Margina
Journal:  Int J Oncol       Date:  2018-10-16       Impact factor: 5.650

  3 in total
  1 in total

1.  Pyroptosis-related gene-based prognostic signature for predicting the overall survival of oral squamous cell carcinoma patients.

Authors:  Deliang Zeng; Xiao Wang; Shuning Zhang; Ao Zheng; Qingfeng Huang; Lingyan Cao
Journal:  Front Surg       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.